Experimental findings demonstrate equol reduces basophil activation, suggesting isoflavones may serve as anti-allergic agents.
These results suggest that equol might be a potential candidate as an anti-allergic agent as well as related isoflavones.
No takes yet. Share an insight, caveat, or question.
Yamaki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: